Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis.

Neurology and therapy·2026
Same author

Neurofilament Light Chain in Cerebrospinal Fluid and Blood Identifies Patients With Minimal and Overt Hepatic Encephalopathy.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Brain : a journal of neurology·2026
Same author

Feasibility Study of an Early, Interdisciplinary, Non-Pharmacological Intervention for Patients at Risk of Developing Persistent Post-Traumatic Headache: The PTHEENOT intervention.

Journal of multidisciplinary healthcare·2026
Same author

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

[Developing anti-CD20 molecules and B cell depletion in multiple sclerosis].

Ideggyogyaszati szemle·2026

Related Experiment Video

Updated: Dec 23, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Patient Attitudes to Routine Cognitive Testing in Multiple Sclerosis.

Gitte Lee Mortensen1, Ásta Theódórsdóttir2, Tobias Sejbæk3,4,5

  • 1AnthroConsult, Århus C 8000, Denmark.

Patient Preference and Adherence
|April 21, 2020
PubMed
Summary

Multiple sclerosis patients widely support routine cognitive testing, which can impact quality of life differently across disease types. This testing is crucial for comprehensive care, addressing both physical and cognitive challenges in multiple sclerosis (MS).

Keywords:
cognitive impairmentcognitive testingmultiple sclerosispatient preferencesquality of life

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.6K
Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.4K

Related Experiment Videos

Last Updated: Dec 23, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.6K
Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.4K

Area of Science:

  • Neurology
  • Neuropsychology
  • Quality of Life Research

Background:

  • Cognitive dysfunction (CD) is increasingly recognized in multiple sclerosis (MS).
  • Neuropsychological tests exist to monitor cognitive changes in MS patients.
  • Patient attitudes towards routine cognitive testing in MS are largely unexplored.

Purpose of the Study:

  • To explore the attitudes of multiple sclerosis patients towards the introduction of routine cognitive testing.
  • To understand the relationship between quality of life (QoL) impact of CD and patient attitudes.

Main Methods:

  • Qualitative study involving semi-structured interviews with 12 Danish MS patients.
  • Participants represented diverse perspectives on CD, including relapsing-remitting MS (RRMS) and secondary-progressive MS (SPMS) subtypes.
  • Data analysis employed a constructivist approach to examine QoL impact and attitudes towards cognitive testing using the Symbol Digit Modalities Test (SDMT).

Main Results:

  • Subjective and objective cognitive dysfunction (CD) did not always align, nor directly correlate with poorer quality of life (QoL).
  • CD impacted QoL more significantly in RRMS patients with higher SDMT scores compared to SPMS patients.
  • All patients supported routine cognitive testing, citing reasons such as research support, treatment optimization, and documenting an invisible symptom.

Conclusions:

  • Cognitive dysfunction (CD) can affect all aspects of multiple sclerosis (MS) patients' quality of life (QoL).
  • Patients across all MS phases widely support routine cognitive testing.
  • Comprehensive care for MS should integrate management of both physical and cognitive impairments.